| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $422K | — | +197.2% |
| Cost of Revenue | $11K | — | -79.6% |
| Gross Profit | $411K | — | +367.0% |
| R&D Expense | $9.1M | — | -56.2% |
| SG&A Expense | $7.0M | — | -8.6% |
| Operating Income | -$15.7M | — | +44.6% |
| Pre-tax Income | -$15.0M | — | +47.6% |
| Income Tax | $0 | — | — |
| Net Income | -$15.0M | — | +47.6% |
| EPS (Basic) | -$0.11 | — | +45.0% |
| EPS (Diluted) | -$0.11 | — | +45.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.7M | -49.8% | -91.3% |
| Short-term Investments | $64.4M | -12.8% | -10.1% |
| Accounts Receivable | $0 | — | -100.0% |
| Current Assets | $102.9M | -13.3% | -39.4% |
| Total Assets | $115.1M | -12.4% | -37.9% |
| Current Liabilities | $10.5M | -23.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.6M | — | -26.8% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $10.0M | — | +122.5% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$15.6M | — | -26.7% |
| -45.7% |
| Total Liabilities | $65.7M | -4.9% | -9.4% |
| Stockholders' Equity | $49.4M | -20.7% | -56.2% |